Paul Tudor Jones Axogen, Inc. Transaction History
Tudor Investment Corp Et Al
- $25.1 Billion
- Q4 2024
A detailed history of Paul Tudor Jones (Tudor Investment Corp Et Al) transactions in Axogen, Inc. stock. As of the latest transaction made, Tudor Investment Corp Et Al holds 87,551 shares of AXGN stock, worth $1.69 Million. This represents 0.01% of its overall portfolio holdings.
Number of Shares
87,551
Previous 112,352
22.07%
Holding current value
$1.69 Million
Previous $1.58 Million
8.44%
% of portfolio
0.01%
Previous 0.01%
Shares
2 transactions
Others Institutions Holding AXGN
# of Institutions
179Shares Held
36.2MCall Options Held
82.6KPut Options Held
1.1K-
First Light Asset Management, LLC Edina, MN4.51MShares$86.9 Million7.26% of portfolio
-
Black Rock Inc. New York, NY3.25MShares$62.7 Million0.0% of portfolio
-
Soleus Capital Management, L.P. Greenwich, CT2.96MShares$57 Million3.39% of portfolio
-
Morgan Stanley New York, NY2.43MShares$46.9 Million0.0% of portfolio
-
Vanguard Group Inc Valley Forge, PA2.43MShares$46.8 Million0.0% of portfolio
About Axogen, Inc.
- Ticker AXGN
- Exchange NASDAQ
- Sector Healthcare
- Industry Medical Devices
- Shares Outstandng 42,283,700
- Market Cap $816M
- Description
- AxoGen, Inc., together with its subsidiaries, develops and markets surgical solutions for physical damage or transection to peripheral nerves. The company's products include Avance Nerve Graft, a biologically active off-the-shelf processed human nerve allograft for bridging severed nerves without the comorbidities associated with a second surgic...